Human Phase I Metabolism of the Novel Synthetic Cannabinoid 5f-Cumyl-Pegaclone

Forensic Toxicology - Japan
doi 10.1007/s11419-018-0447-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

In Vitro and in Vivo Pharmacokinetics and Metabolism of Synthetic Cannabinoids CUMYL-PICA and 5f-Cumyl-Pica

Forensic Toxicology
BiochemistryForensic MedicinePathologyToxicology
2017English

Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Ontogeny of Phase I Metabolism of Drugs

Journal of Clinical Pharmacology
Pharmacology
2019English

Analysis and Clinical Findings of Cases Positive for the Novel Synthetic Cannabinoid Receptor Agonist MDMB-CHMICA

Clinical Toxicology
MedicineToxicology
2016English

Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes

AAPS Journal
Pharmaceutical Science
2017English

Alterations of the Hematologic Cells in Synthetic Cannabinoid Users

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2017English

Phase I Study of Solulin, a Novel Recombinant Soluble Human Thrombomodulin Analogue

Thrombosis and Haemostasis
Hematology
2011English

Class I Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Human Tumor Proliferation

Clinical Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy